Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 228

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome

Camoin-Jau, Laurence, Sabatier, Florence, Arnoux, Dominique, Anfosso, Francine, Bardin, Nathalie, Veit, Véronique, Combes, Valéry, Gentile, Stéphanie, Moal, Valérie, Sanmarco, Marielle, Sampol, José, Dignat-George, Françoise·2004·Thrombosis and Haemostasis

Abstract

Summary: The antiphospholipid syndrome (APS) refers to persistent antiphospholipid antibodies (aPL) associated with thrombotic and/or obstetrical complications. The endothelial cell is a target of aPL which can induce a procoagulant and proinflammatory endothelial phenotype, as reported both in vivo and in vitro. Microparticle production is a hallmark of cell activation. In the present study, the presence of endothelial microparticles (EMP) in the plasma of APS patients was investigated. To determine if there is a correlation with certain biological and clinical features, EMP levels were measured in thrombosis-free patients with systemic lupus erythematosus (SLE) patients, with and without aPL, in patients with non aPL-related thrombosis, as well as in healthy controls. Compared to healthy subjects, elevated plasma levels of EMP were found in patients with APS and in SLE patients with aPL, but not in SLE patients without aPL or in non aPL-related thrombosis. EMP levels were also associated with Lupus Anticoagulant (LA) detected by a positive Dilute Russell’s Viper Venom time (DRVVT). In parallel, we analyzed the capacity of these plasma to induce vesiculation of cultured endothelial cells. We demonstrated an increase of EMP generated in response to plasma from patients with autoimmune diseases. Interestingly, only APS plasma induced the release of EMP with procoagulant activity. These ex vivo and in vitro observations indicate that generation of EMP in APS and SLE patients results from an autoimmune process involving aPL. Production of procoagulant microparticles in APS patients may represent a new pathogenic mechanism for the thrombotic complications of this disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1160/th03-07-0487

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 228

Metadata

Authors
Camoin-Jau, L., Sabatier, F., Arnoux, D., Anfosso, F., Bardin, N., Veit, V., Combes, V., Gentile, S., Moal, V., Sanmarco, M., Sampol, J., & Dignat-George, F.
Venue
Thrombosis and Haemostasis
Published
2004
Volume
91
Issue
04
Pages
667-673
ISSN
  • 0340-6245 (ISSN-L)
  • 2567-689X
OpenAlex
W2133666585
Cited by
228
References
3
FWCI
6.62
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. https://app.cochat.ai/papers/10.1160/th03-07-0487
The paper
Camoin-Jau, L., Sabatier, F., Arnoux, D., Anfosso, F., Bardin, N., Veit, V., Combes, V., Gentile, S., Moal, V., Sanmarco, M., Sampol, J., & Dignat-George, F. (2004). Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome. Thrombosis and Haemostasis. https://doi.org/10.1160/th03-07-0487

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.